Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity

被引:0
|
作者
Lozanska B. [1 ]
Georgieva M. [1 ]
Miloshev G. [1 ]
Xenodochidis C. [2 ,3 ]
机构
[1] Laboratory of Molecular Genetics, Institute of Molecular Biology “Acad. Roumen Tsanev”, Bulgarian Academy of Sciences, Sofia
[2] Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University – Plovdiv
[3] Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia
关键词
Age-related disease; Ageing; Mao-a; Mao-b; Maois (monoamine oxidase inhibitors); Monoamine oxidase (mao); Neurodegenerative disease;
D O I
10.7546/IJBA.2022.26.4.000879
中图分类号
学科分类号
摘要
Disease and ageing are linked in many ways and especially by the mechanisms they share. For many diseases, the process of ageing is the main culprit leading to the pathology. Hence, it is crucial to understand the process of ageing, and its molecular and cellular mechanisms to have a better understanding and perspective on these age-related diseases. Neurodegenerative diseases are probably the most common types of age-related diseases. Their pathology is complex, however, changes in neurotransmitter levels are almost always present. These types of changes occur during ageing as well, therefore, exploring the link between those processes can give a clue for possible treatments. Monoamine oxidases (MAOs) are enzymes that break down monoamine neurotransmitters and their dysregulation has long been recorded in age-related neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. There is strong evidence that modulating the MAOs’ expression and activity can be beneficial for patients suffering from these illnesses. Herein we critically analyze the literature and make associations among ageing, MAOs’ activity and neurotransmitters’ levels, thus highlighting their role in neurodegenerative diseases © 2022 by the authors. Licensee Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:325 / 338
页数:13
相关论文
共 50 条
  • [21] Activity dependent synaptic refinement by microglia: a regulatory role for neurotransmitters?
    Ormel, P.
    de Goeij, M.
    Celebi, A.
    Hol, E. M.
    Kahn, R.
    de Witte, L.
    GLIA, 2017, 65 : E258 - E259
  • [22] Ageing Gliaceller can cause neurodegeneration
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2019, 139 (03) : 245 - 245
  • [23] Neurodegeneration: a key factor in the ageing gut
    Wade, PR
    Cowen, T
    NEUROGASTROENTEROLOGY AND MOTILITY, 2004, 16 : 19 - 23
  • [24] Sirtuins as a link between ageing and neurodegeneration
    Oldriska, Marques
    Oliveira Rita, M.
    Ferreira, Moita Luis
    Fleming, Outeiro Tiago
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2009, 2009, : 191 - 197
  • [25] Brain ageing and neurodegeneration in bipolar disorder
    Zovetti, Niccolo
    Rossetti, Maria Gloria
    Perlini, Cinzia
    Brambilla, Paolo
    Bellani, Marcella
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 323 : 171 - 175
  • [27] Neurodegeneration: accelerated ageing or inadequate healthcare?
    Olga Golubnitschaja
    EPMA Journal, 2010, 1 (2): : 211 - 215
  • [28] Ageing, neurodegeneration, and olfactory and gustatory loss
    Welge-Luessen, A.
    B-ENT, 2009, : 129 - 132
  • [29] Astrocytes at the intersection of ageing, obesity, and neurodegeneration
    Firth, Wyn
    Pye, Katherine R.
    Potter, Paul G. Weightman
    CLINICAL SCIENCE, 2024, 138 (08) : 515 - 536
  • [30] Regional Neurodegeneration in vitro: The Protective Role of Neural Activity
    Mott, Rosalind E.
    von Reyn, Catherine R.
    Firestein, Bonnie L.
    Meaney, David F.
    FRONTIERS IN COMPUTATIONAL NEUROSCIENCE, 2021, 15